Metropolitan Life Insurance Company (MetLife)’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,328
| Closed | -$236K | – | 1710 |
|
|
2024
Q1 | $236K | Sell |
7,328
-849
| -10% | -$27.4K | 0.01% | 651 |
|
|
2023
Q4 | $235K | Buy |
8,177
+2,335
| +40% | +$67K | 0.01% | 671 |
|
|
2023
Q3 | $162K | Buy |
5,842
+302
| +5% | +$8.36K | 0.01% | 775 |
|
|
2023
Q2 | $148K | Buy |
5,540
+890
| +19% | +$23.8K | 0.01% | 817 |
|
|
2023
Q1 | $101K | Sell |
4,650
-11
| -0.2% | -$238 | 0.01% | 988 |
|
|
2022
Q4 | $111K | Buy |
4,661
+180
| +4% | +$4.29K | 0.01% | 993 |
|
|
2022
Q3 | $88.4K | Buy |
4,481
+576
| +15% | +$11.4K | ﹤0.01% | 1086 |
|
|
2022
Q2 | $76.1K | Hold |
3,905
| – | – | ﹤0.01% | 1227 |
|
|
2022
Q1 | $99.6K | Sell |
3,905
-12,643
| -76% | -$323K | ﹤0.01% | 1197 |
|
|
2021
Q4 | $417K | Hold |
16,548
| – | – | 0.01% | 1555 |
|
|
2021
Q3 | $455K | Hold |
16,548
| – | – | 0.01% | 1524 |
|
|
2021
Q2 | $525K | Buy |
16,548
+5,439
| +49% | +$173K | 0.01% | 1491 |
|
|
2021
Q1 | $510K | Sell |
11,109
-327
| -3% | -$15K | 0.01% | 1397 |
|
|
2020
Q4 | $453K | Hold |
11,436
| – | – | 0.01% | 1422 |
|
|
2020
Q3 | $398K | Buy |
11,436
+6,477
| +131% | +$225K | 0.01% | 1369 |
|
|
2020
Q2 | $157K | Hold |
4,959
| – | – | ﹤0.01% | 1976 |
|
|
2020
Q1 | $109K | Buy |
+4,959
| New | +$109K | ﹤0.01% | 1984 |
|